Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ – Get Free Report)’s stock price shot up 1.2% during trading on Friday . The stock traded as high as $4.1150 and last traded at $4.07. 163,536 shares traded hands during mid-day trading, a decline of 21% from the average session volume of 205,918 shares. The stock had previously closed at $4.02.
Health Sciences Acquisitions Co. 2 Price Performance
The company’s fifty day simple moving average is $4.10 and its 200 day simple moving average is $4.26.
Health Sciences Acquisitions Co. 2 Company Profile
Health Sciences Acquisitions Co 2 is a Delaware‐incorporated special purpose acquisition company (SPAC) established to pursue a business combination with a company in the health sciences sector. Listed on the Nasdaq under the ticker HSAQ, the firm completed an initial public offering in early 2021, raising capital through the sale of units comprised of common stock and warrants.
As a blank‐check vehicle, Health Sciences Acquisitions Co 2 does not engage in commercial operations; rather, it focuses exclusively on identifying and combining with a private company operating in biotechnology, pharmaceuticals, medical devices or related life sciences fields.
Recommended Stories
- Five stocks we like better than Health Sciences Acquisitions Co. 2
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Receive News & Ratings for Health Sciences Acquisitions Co. 2 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Sciences Acquisitions Co. 2 and related companies with MarketBeat.com's FREE daily email newsletter.
